Gi Hyeok Yang

This inventor holds 17 USPTO granted patents and 9 published patent applications, plus 4 CIPO patents and 8 EPO patents, primarily in Botulinum Toxin Formulations. Top assignee: Medytox Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gi Hyeok Yang. Retrieved from https://idiyas.com/inventor/gi-hyeok-yang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 9)

% Patents Active = 94.1

CIPO Patents = 4

EPO Patents = 8 (Patent Applications = 10)

Average Co-Inventor Count = 4.6

ph-index = 7

Forward Citations = 111(Granted Patents)

Location History:

Chungcheongnam-do, KR (2015 - 2023)
Cheonan-si, KR (2013 - 2024)

Company Filing History:

17 out of 21

Medytox Inc.

patents

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Botulinum Toxin

Pharmaceutical Composition

Fat Reduction

Bile Acids

Stability

Lyophilized Preparation

Recombinant Polynucleotide

Adhesion Prevention

Temperature Sensitivity

Long Lasting Effect

Isolating Method

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12377137 - Long lasting effect of new botulinum toxin formulations (2025-08-05),

2. 12274739 - Pharmaceutical liquid composition of botulinum toxin with improved stability (2025-04-14),

3. 11957741 - Long lasting effect of new botulinum toxin formulations (2024-04-16),

4. 11596673 - Long lasting effect of new botulinum toxin formulations (2023-03-07),

5. 11590212 - Long lasting effect of new botulinum toxin formulations (2023-02-28),

6. 11517576 - Methods and compositions of bile acids and salts for reduction of fat (2022-12-06),

7. 11331598 - Method of isolating botulinum toxin from botulinum toxin-containing solution (2022-05-17),

8. 11198859 - Recombinant polynucleotide coding for polypeptide comprising reporter moiety, substrate moiety and destabilizing moiety, host cell comprising same and use of same (2021-12-14),

9. 10729700 - Methods and compositions of bile acids and salts for reduction of fat (2020-08-04),

10. 10293034 - Pharmaceutical liquid composition of botulinum toxin with improved stability and method of use (2019-05-21),

11. 10143728 - Long lasting effect of new botulinum toxin formulations (2018-12-04),

12. 10105387 - Temperature sensitive adhesion prevention composition and use thereof (2018-10-23),

13. 9480731 - Long lasting effect of new botulinum toxin formulations (2016-11-01),

14. 9220780 - Pharmaceutical liquid composition of botulinum toxin with improved stability (2015-12-29),

15. 9198958 - Lyophilized preparation of botulinum toxin (2015-12-01),

Title: The Innovative Journey of Inventor Gi Hyeok Yang

Introduction: Gi Hyeok Yang, a talented inventor hailing from Chungcheongnam-do, South Korea, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Yang's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, as well as a novel wearable device aimed at enhancing personal health and fitness tracking.

Career Highlights: With a career spanning over two decades, Yang has established himself as a visionary in the tech industry. His innovative solutions have garnered international recognition, earning him prestigious awards and accolades.

Collaborations: Throughout his career, Yang has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has led to the successful development and commercialization of his groundbreaking ideas.

Conclusion: Gi Hyeok Yang's relentless passion for innovation and his unwavering commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions. His remarkable journey continues to inspire aspiring inventors and shape the future of technological advancements.

Profile summary based on public USPTO records.